Company Filing History:
Years Active: 2011-2013
Title: Käthe Gooβen: Innovator in Antiviral Medicament Development
Introduction
Käthe Gooβen is a notable inventor based in Kaiserslautern, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral agents. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry positively.
Latest Patents
Gooβen's latest patents focus on processes for the preparation of dihydroquinazolines. One of his inventions involves a process for creating methyl (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoro-methyl)-phenyl]-3,4-dihydroquinazolin-4-yl}acetate (2S,3S)-2,3-bis[(4-methylbenzoyl)-oxy]succinic acid salt. These compounds are essential for the production of antiviral medicaments. Another patent also relates to a process for the preparation of dihydroquinazolines, specifically {8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid, which serves as an antiviral agent in medicament production.
Career Highlights
Käthe Gooβen is currently associated with Aicuris GmbH & Co. KG, where he continues to innovate in the field of antiviral research. His work has garnered attention for its potential applications in treating viral infections.
Collaborations
Gooβen collaborates with talented individuals such as Oliver Kuhn and Mathias Berwe, contributing to a dynamic research environment that fosters innovation.
Conclusion
Käthe Gooβen's contributions to antiviral medicament development through his patents highlight his role as a significant inventor in the pharmaceutical industry. His ongoing work promises to advance the field and improve treatment options for viral infections.